2m 2m 2m 2m 2m 2m 2m
INMODE (INMD)
NASDAQ
$13.49-$0.010 (-0.07%)
Price as of Jun 03, 2026 6:48 PM EDT- $1.2BMarket Cap
- -8.23%1-Year Change
- Medical DevicesIndustry
INMODE (INMD)
$13.49-$0.010 (-0.07%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 370.5M -6.16% | 394.8M -19.76% | 492.0M +8.32% | 454.3M +27.05% | |
Cost of Revenue | 79.5M +2.28% | 77.8M -3.66% | 80.7M +9.83% | 73.5M +37.12% | |
Gross Profit | 291.0M -8.23% | 317.1M -22.92% | 411.3M +8.02% | 380.8M +25.27% | |
Sales and Marketing Expense | 180.6M -0.43% | 181.4M -6.05% | 193.0M +20.22% | 160.6M +34.54% | |
Research and Development Expense | -13.3M +1.39% | -13.1M -2.04% | -13.4M +7.93% | -12.4M +30.35% | |
Depreciation and Amortization Expense | 695,000 -4.53% | 728,000 +16.85% | 623,000 -8.38% | 680,000 +31.53% | |
Total Operating Expenses | 205.6M +0.51% | 204.5M -5.17% | 215.7M +17.90% | 182.9M +34.02% | |
Operating Profit | 85.4M -24.12% | 112.5M -42.49% | 195.7M -1.11% | 197.9M +18.14% | |
Interest Income | 21.6M -35.66% | 33.5M N/A | 0 +100.00% | -71,000 -59.43% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 21.6M -35.66% | 33.5M N/A | 0 +100.00% | -71,000 -59.43% | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | 4.7M N/A | N/A N/A | |
Income before Taxes | 110.3M -23.10% | 143.5M -33.97% | 217.3M +7.84% | 201.5M +19.92% | |
Income Taxes | 16.5M +143.64% | -37.8M -295.40% | 19.3M -51.56% | 39.9M +1,264.28% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 93.8M -48.24% | 181.3M -8.41% | 197.9M +22.54% | 161.5M -2.09% | |
Net Income from Continuing Operations Applicable to Common | 110.3M -23.10% | 143.5M -33.97% | 217.3M +7.84% | 201.5M +19.92% | |
Basic EPS and Net Income | 1.45 -36.68% | 2.29 -3.38% | 2.37 +20.92% | 1.96 -3.45% | |
Diluted EPS and Net Income | 1.43 -36.44% | 2.25 -2.17% | 2.30 +21.69% | 1.89 -1.56% | |
Basic Weighted Average Shares | 64.6M -18.50% | 79.3M -5.06% | 83.5M +1.27% | 82.5M +1.27% | |
Diluted Weighted Average Shares | 65.4M -18.80% | 80.6M -6.23% | 86.0M +0.64% | 85.4M -0.71% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 302.5M +94.78% | 155.3M +7.56% | 144.4M +48.05% | 97.5M +43.15% | |
Short-Term Investments | 83.6M -68.76% | 267.7M -28.36% | 373.6M -0.25% | 374.6M +27.18% | |
Cash and Cash Equivalents and Short-Term Investments | 386.2M -8.71% | 423.0M -18.35% | 518.1M +9.73% | 472.1M +30.18% | |
Total Current Assets | 698.6M -2.22% | 714.5M -15.48% | 845.3M +34.31% | 629.4M +33.88% | |
Accumulated Depreciation | 4.9M +16.61% | 4.2M +21.06% | 3.5M +21.98% | 2.8M +31.57% | |
Property and Plant and Equipment and Net | 2.6M +11.93% | 2.3M -2.52% | 2.4M +3.66% | 2.3M +63.68% | |
Total Long-Term Assets | 67.8M -4.78% | 71.2M +296.61% | 18.0M +19.40% | 15.0M +78.45% | |
Total Assets | 766.4M -2.45% | 785.7M -8.99% | 863.3M +33.97% | 644.4M +34.66% | |
Income Taxes Payable | 761,000 -18.44% | 933,000 -51.36% | 1.9M -90.03% | 19.2M +1,452.95% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 70.7M +1.28% | 69.9M +8.91% | 64.1M -21.80% | 82.0M +58.19% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 12.5M +4.03% | 12.0M +1.91% | 11.8M +51.56% | 7.8M -28.63% | |
Total Liabilities | 83.2M +1.68% | 81.9M +7.82% | 75.9M -15.45% | 89.8M +43.12% | |
Retained Earnings | 968.5M +10.73% | 874.7M +26.14% | 693.4M +39.94% | 495.5M +48.36% | |
Total Stockholders Equity | 683.2M -2.93% | 703.8M -10.61% | 787.4M +41.97% | 554.6M +33.39% | |
Total Shares Outstanding | 63.4M -8.91% | 69.6M -17.17% | 84.0M +1.74% | 82.5M -0.52% | |
Cash Flow | |||||
Cash from Operating Activities | 85.3M -35.73% | 132.7M -24.97% | 176.8M -2.62% | 181.6M +3.83% | |
Capital Expenditures | 972,000 +45.29% | 669,000 -5.11% | 705,000 -55.24% | 1.6M +67.73% | |
Cash from Investing Activities | 186.0M +14.69% | 162.2M +219.21% | -136.1M +24.29% | -109.5M -31.62% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -126.1M -55.42% | -282.8M -5,237.55% | 5.5M +113.40% | -41.1M +173.50% | |
Financials Ratio | |||||
Gross Margin | 78.54% -2.21% | 80.31% -3.94% | 83.60% -0.27% | 83.82% -1.40% | |
Operating Margin | 23.05% -19.14% | 28.50% -28.32% | 39.76% -8.70% | 43.55% -7.01% | |
Return on Assets | 12.09% -45.01% | 21.99% -16.26% | 26.25% -8.73% | 28.77% -32.49% | |
Return on Equity | 13.53% -44.35% | 24.31% -17.57% | 29.50% -11.39% | 33.29% -32.43% | |
Revenue Growth | -6.16% -68.82% | -19.76% -337.62% | 8.32% -69.25% | 27.05% -63.20% | |
Current Ratio | 9.88 -3.45% | 10.23 -22.40% | 13.18 +71.77% | 7.67 -15.37% | |
Cash Ratio | 4.28 +92.32% | 2.22 -1.24% | 2.25 +89.34% | 1.19 -9.50% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow